Pascaline Boudou-Rouquette相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab

接受 Nivolumab 治疗的转移性肾细胞癌患者的能量消耗与疗效的关系

doi:10.3390/cancers14133214

Johanna Noel, Anne Jouinot, Jérôme Alexandre, Guillaume Ulmann, Marie Bretagne, Zahra Castel-Ajgal, Sixtine De Percin, Clémentine Vaquin-Villeminey, Marie-Pierre Revel, Michael Peyromaure, Pascaline Boudou-Rouquette, Jennifer Arrondeau, Ithar Gataa, Jean-Philippe Durand, François Goldwasser, Olivier

细胞生物学

发表日期：2022

文献求助收藏

Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTIM Cohort: The ELY study

开发和验证一种宿主依赖性、PDL1 非依赖性的生物标志物，用于预测 CERTIM 队列中接受抗 PD1 免疫检查点抑制剂 (ICI) 治疗的转移性非小细胞肺癌 (mNSCLC) 患者的 6 个月无进展生存期：ELY 研究

期刊:EBioMedicine

影响因子:9.7

doi:10.1016/j.ebiom.2021.103630

Pascaline Boudou-Rouquette, Jennifer Arrondeau, Claire Gervais, Jean-Philippe Durand, Elizabeth Fabre, Sixtine De Percin, Clémentine Vaquin Villeminey, Anne-Catherine Piketty, Nathalie Rassy, Guillaume Ulmann, Diane Damotte, Audrey Mansuet-Lupo, Frédérique Giraud, Marco Alifano, Marie Wislez, Jérôme

发表日期：2021

文献求助收藏

Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study

可溶性 PD-1、PD-L1、VEGFA、CD40 配体和 CD44 对晚期非小细胞肺癌 Nivolumab 治疗的预测价值：一项病例对照研究

doi:10.3390/cancers12020473

Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux-Leprieur, Elizabeth Fabre, Marie Wislez, Marco Alifano, Karen Leroy, Pascaline Boudou-Rouquette, Camille Tlemsani, Nihel Khoudour, Jennifer Arrondeau, Audrey Thomas-Schoemann, Hélène Blons, Audrey Mansuet-Lupo, Diane Damotte, Michel Vidal, François Go

发表日期：2020

文献求助收藏

Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers

胚胎特征可将儿童和成人横纹肌样瘤与其他 SMARCB1 缺陷型癌症区分开来

期刊:Oncotarget

doi:10.18632/oncotarget.15939

Wilfrid Richer, Julien Masliah-Planchon, Nathalie Clement, Irene Jimenez, Laetitia Maillot, David Gentien, Benoît Albaud, Walid Chemlali, Christine Galant, Frederique Larousserie, Pascaline Boudou-Rouquette, Amaury Leruste, Celine Chauvin, Zhi Yan Han, Jean-Michel Coindre, Pascale Varlet, Paul Frene

发表日期：2017

文献求助收藏